Pfizer
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
Labcorp’s (NYSE:LH) assay has been cleared by the U.S. drug regulator for use with Pfizer's (NYSE:PFE) newly approved gene therapy to treat patients with hemoph...
More than 50 abstracts, including 11 oral presentations, span Pfizer’s robust portfolio of approved and pipeline therapies across its key tumor areas and core s...
As the calendar flips from April to May, the upcoming week is set to bring a flurry of earnings reports from some of the world's most prominent companies. At th...
Analyst ratings
64%
of 25 ratingsMore PFE News
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-...
Loading... Loading... Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled Acuitas’ lawsuit over credit for inventions...
Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. The drugmaker s...
Normally an approval from the Food and Drug Administration (FDA) is good news for a biotech stock, and for Pfizer (NYSE:PFE), it should have been no exception....
Analysts on Wall Street project that Pfizer (PFE) will announce quarterly earnings of $0.56 per share in its forthcoming report, representing a decline of 54.5%...
This week's dividend activity included increased payouts from MetLife (NYSE:MET) and Invesco (IVZ) as well as declarations from companies like General Motors (N...
Pfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatmen...
